These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 27126650)

  • 1. Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.
    Chan NC; Eikelboom JW; Weitz JI
    Circ Res; 2016 Apr; 118(9):1409-24. PubMed ID: 27126650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
    Bejjani A; Khairani CD; Assi A; Piazza G; Sadeghipour P; Talasaz AH; Fanikos J; Connors JM; Siegal DM; Barnes GD; Martin KA; Angiolillo DJ; Kleindorfer D; Monreal M; Jimenez D; Middeldorp S; Elkind MSV; Ruff CT; Goldhaber SZ; Krumholz HM; Mehran R; Cushman M; Eikelboom JW; Lip GYH; Weitz JI; Lopes RD; Bikdeli B
    J Am Coll Cardiol; 2024 Jan; 83(3):444-465. PubMed ID: 38233019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs).
    van Gorp RH; Schurgers LJ
    Nutrients; 2015 Nov; 7(11):9538-57. PubMed ID: 26593943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
    De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
    Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations.
    van Es N; Büller HR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():125-31. PubMed ID: 26637711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current challenges and future prospects in oral anticoagulant therapy.
    Czuprynska J; Patel JP; Arya R
    Br J Haematol; 2017 Sep; 178(6):838-851. PubMed ID: 28573648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent evidence for direct oral anticoagulants in chronic kidney disease.
    Ha JT; Badve SV; Jun M
    Curr Opin Nephrol Hypertens; 2019 May; 28(3):251-261. PubMed ID: 30789840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Direct Oral Anticoagulants in Special Populations.
    Li A; Lopes RD; Garcia DA
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1053-71. PubMed ID: 27637307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis.
    Yaghi S; Saldanha IJ; Misquith C; Zaidat B; Shah A; Joudi K; Persaud B; Abdul Khalek F; Shu L; de Havenon A; Mistry EA; Bakradze E; Goldstein ED; Reagan J; Theodorou A; Palaiodimou L; Furie K; Field TS; Tsivgoulis G; Mac Grory B
    Stroke; 2022 Oct; 53(10):3014-3024. PubMed ID: 35938419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism.
    Riva N; Ageno W
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1035-51. PubMed ID: 27637306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
    Dufrost V; Wahl D; Zuily S
    Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
    Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review.
    Bertoletti L; Benhamou Y; Béjot Y; Marechaux S; Cheggour S; Aleil B; Lellouche N; Dillinger JG; Delluc A
    Blood Rev; 2018 Jul; 32(4):272-279. PubMed ID: 29402471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials.
    Di Minno MN; Lupoli R; Di Minno A; Ambrosino P; Scalera A; Dentali F
    Ann Med; 2015 Feb; 47(1):61-8. PubMed ID: 25665582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin K antagonist, direct oral anticoagulants: Where is the truth?].
    Laroche JP; Schved JF
    J Mal Vasc; 2016 Dec; 41(6):383-388. PubMed ID: 27817997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
    Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
    Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulant Use in Atypical Thrombosis-Related Conditions.
    Chang C; Hoyos M; Owusu Y; Elewa H
    Ann Pharmacother; 2018 Feb; 52(2):185-197. PubMed ID: 28918657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel oral anticoagulants in acute coronary syndrome.
    Costopoulos C; Niespialowska-Steuden M; Kukreja N; Gorog DA
    Int J Cardiol; 2013 Sep; 167(6):2449-55. PubMed ID: 22989603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutic uses of direct-acting oral anticoagulants: An evidence-based perspective.
    Raschi E; Bianchin M; De Ponti R; De Ponti F; Ageno W
    Pharmacol Res; 2017 Jun; 120():206-218. PubMed ID: 28366835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.